Retraction
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
Paper Information
Record ID:
39627
Author(s):
Journal:
Publication Date:
February 28, 2010
Retraction Date:
October 06, 2022
(3.1 years years ago)
Subjects:
Institutions:
- Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA
- Wright State University, Dayton, Ohio, USA
- Department of Molecular and Cellular Biochemistry, The Ohio State University, Columbus, Ohio, USA
- Integrated Biomedical Graduate Program, The Ohio State University, Columbus, Ohio, USA
- The Mannheimer Foundation, Inc., Homestead, Florida, USA
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Springer - Nature Publishing Group
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (696)
696
Total Citations47
Post-Retraction(6.8%)
647
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
4
Within 30 days
20
Within 1 year
9
After 2+ years
967
Days since retraction (latest)
Paper citing Rescue of the spinal muscular atrophy phenotype in...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Rescue of the spinal muscular atrophy phenotype in...
Unknown Authors
Unknown Journal
Published: Unknown
Advances in viral vector-based delivery systems for gene therapy: a comprehensive review
Kuldeep Singh, Divya Jain, Pranshul Sethi et al. (9 authors)
3 Biotech
Published: May 2025
967 days after retraction
Bibliometrics and Visualization Analysis of Neuromuscular Junction Model
Xincheng Du, Wenwen Liu, Jin Geng et al. (5 authors)
Neurology India
Published: May 2025
938 days after retraction
Paper citing Rescue of the spinal muscular atrophy phenotype in...
Unknown Authors
Unknown Journal
Published: Mar 2025
889 days after retraction
Treating neuromuscular diseases: unveiling gene therapy breakthroughs and pioneering future applications
Yu‐Fu Wu, Jun‐An Chen, Yuh‐Jyh Jong
Journal of Biomedical Science
Open Access
Published: Feb 2025
3 citations
3 citations
869 days after retraction
Paper citing Rescue of the spinal muscular atrophy phenotype in...
Unknown Authors
Unknown Journal
Published: Feb 2025
849 days after retraction
Spinal Muscular Atrophy (SMA): Treatment strategies, challenges and future prospects
Nikunja Kishor Mishra, Amiyakanta Mishra
Deleted Journal
Published: Jan 2025
1 citation
1 citation
818 days after retraction
Gene replacement therapy to restore polyamine metabolism in a Snyder-Robinson syndrome mouse model
Oluwaseun Akinyele, Krystal Tran, Marie A. Johnson et al. (4 authors)
Methods in enzymology on CD-ROM/Methods in enzymology
Published: Jan 2025
818 days after retraction
Paper citing Rescue of the spinal muscular atrophy phenotype in...
Unknown Authors
Unknown Journal
Published: Dec 2024
787 days after retraction
Spinal muscular atrophy
Megan A. Waldrop, Stephen J. Kolb, John T. Kissel et al. (4 authors)
Elsevier eBooks
Published: Oct 2024
1 citation
1 citation
736 days after retraction
Current Treatment Process and Challenges for Spinal Muscular Atrophy (SMA)
Nikunja Kishor Mishra, Amiyakanta Mishra, Pravat Kumar Sahoo et al. (4 authors)
Research Journal of Pharmacy and Technology
Published: Aug 2024
690 days after retraction
Current developments of gene therapy in human diseases
Fanfei Liu, Ruiting Li, Zilin Zhu et al. (5 authors)
MedComm
Open Access
Published: Aug 2024
7 citations
7 citations
680 days after retraction
Recent Advance in Disease Modifying Therapies for Spinal Muscular Atrophy
Li‐Kai Tsai, Chen-Hung Ting, Yo-Tsen Liu et al. (5 authors)
Acta Neurologica Taiwanica
Published: Jul 2024
634 days after retraction
Immune responses to central nervous system directed adeno-associated virus gene therapy: Does direct CNS delivery make a difference?
Ashley L. Harkins, Prajakta P Ambegaokar, Allison M. Keeler
Neurotherapeutics
Open Access
Published: Jul 2024
10 citations
10 citations
634 days after retraction
AAV gene replacement therapy for treating MPS IIIC: Facilitating bystander effects via EV‐mRNA cargo
Tierra A. Bobo, Michael J. Robinson, Christopher Tofade et al. (7 authors)
Journal of Extracellular Vesicles
Open Access
Published: Jul 2024
2 citations
2 citations
634 days after retraction
Adeno-associated virus vector delivery to the brain: Technology advancements and clinical applications
Dezhuang Ye, Chinwendu Chukwu, Yaoheng Yang et al. (5 authors)
Advanced Drug Delivery Reviews
Open Access
Published: Jun 2024
13 citations
13 citations
622 days after retraction
AAV9-Mediated Intra-Striatal Delivery of<i>GNAO1</i>Reduces Hyperlocomotion in<i>Gnao1</i>Heterozygous R209H Mutant Mice
Alex J. Roy, Jeffrey R. Leipprandt, Joseph R. Patterson et al. (11 authors)
Journal of Pharmacology and Experimental Therapeutics
Open Access
Published: Jun 2024
615 days after retraction
Advances in gene therapy approaches targeting neuro-inflammation in neurodegenerative diseases
Kuldeep Singh, Pranshul Sethi, Samaresh Datta et al. (10 authors)
Ageing Research Reviews
Published: May 2024
24 citations
24 citations
580 days after retraction
Approaches to pathogenetic therapy of spinal muscular atrophy in children and newborns
S. B. Artemyeva, О. А. Shidlovskaya, Yu. О. Papina et al. (8 authors)
Neuromuscular Diseases
Open Access
Published: Mar 2024
1 citation
1 citation
512 days after retraction
Improved gene therapy for spinal muscular atrophy in mice using codon-optimized hSMN1 transgene and hSMN1 gene-derived promotor
Qing Xie, Xiupeng Chen, Hong Ma et al. (17 authors)
EMBO Molecular Medicine
Open Access
Published: Feb 2024
15 citations
15 citations
509 days after retraction
Adeno‐Associated Virus‐Encapsulated Alginate Microspheres Loaded in Collagen Gel Carriers for Localized Gene Transfer
Yuta Kurashina, Sho Kurihara, Takeshi Kubota et al. (14 authors)
Advanced Healthcare Materials
Open Access
Published: Jan 2024
3 citations
3 citations
466 days after retraction
Gene therapy for mitochondrial disorders
Nandaki Keshavan, Michal Minczuk, Carlo Viscomi et al. (4 authors)
Journal of Inherited Metabolic Disease
Open Access
Published: Jan 2024
8 citations
8 citations
452 days after retraction
Novel treatments for neurodegenerative disorders predominantly presenting in children and young adults
D. Isum Ward, Mohamad Saifeddine, Maya Gogoi
Elsevier eBooks
Published: Jan 2024
452 days after retraction
CNS Drug Delivery in Stroke: Improving Therapeutic Translation From the Bench to the Bedside
Patrick T. Ronaldson, Erica I. Williams, Robert D. Betterton et al. (6 authors)
Stroke
Published: Dec 2023
7 citations
7 citations
442 days after retraction
Advances of Genome Editing with CRISPR/Cas9 in Neurodegeneration: The Right Path towards Therapy
Aleksandr Klinkovskij, М. В. Шепелев, Y. A. Isaakyan et al. (5 authors)
Biomedicines
Open Access
Published: Dec 2023
10 citations
10 citations
437 days after retraction
Comprehensive Comparison of AAV Purification Methods: Iodixanol Gradient Centrifugation vs. Immuno-Affinity Chromatography
Anh K. Lam, Patrick L. Mulcrone, Dylan Frabutt et al. (12 authors)
Advances in Cell and Gene Therapy
Open Access
Published: Dec 2023
10 citations
10 citations
431 days after retraction
Mitigating aberrant Cdk5 activation alleviates mitochondrial defects and motor neuron disease symptoms in spinal muscular atrophy
Nimrod Miller, Zhaofa Xu, Katharina A. Quinlan et al. (12 authors)
Proceedings of the National Academy of Sciences
Open Access
Published: Nov 2023
2 citations
2 citations
407 days after retraction
<scp>SMN</scp> haploinsufficiency promotes ischemia/ reperfusion‐induced <scp>AKI‐to‐CKD</scp> transition by endoplasmic reticulum stress activation
Xiaoqian Qian, Jingyang Li, S Bian et al. (7 authors)
The FASEB Journal
Open Access
Published: Oct 2023
2 citations
2 citations
384 days after retraction
Lessons from Real Life Experience: Importance of In-House Sequencing and Smart Ratio-Based Real-Time PCR Outperform Multiplex Ligation-Dependent Probe Amplification in Prenatal Diagnosis for Spinal Muscular Atrophy: Bench to Bedside Diagnosis
Gülten Tuncel, Burçin Şanlıdağ, Eray Dırık et al. (6 authors)
Global Medical Genetics
Open Access
Published: Aug 2023
329 days after retraction
Spinal Musküler Atrofi: Tanı, Tarama ve Tedavide Güncel Gelişmeler
Zeliha YÜCEL, Emine Berrin YÜKSEL
Journal of General Health Sciences (JGEHES) Necmettin Erbakan University
Open Access
Published: Aug 2023
1 citation
1 citation
324 days after retraction
IL-1Ra and CCL5, but not IL-10, are promising targets for treating SMA astrocyte-driven pathology
Reilly L. Allison, Mya Suneja, Megan LaCroix et al. (5 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Aug 2023
2 citations
2 citations
312 days after retraction
Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment
Hisahide Nishio, Emma Tabe Eko Niba, Toshio Saito et al. (6 authors)
International Journal of Molecular Sciences
Open Access
Published: Jul 2023
70 citations
70 citations
293 days after retraction
Enhanced expression of the human Survival motor neuron 1 gene from a codon-optimised cDNA transgene in vitro and in vivo
Neda Ali Mohammadi Nafchi, Ellie Chilcott, Sharon J. Brown et al. (6 authors)
Gene Therapy
Open Access
Published: Jun 2023
3 citations
3 citations
252 days after retraction
Early Development of Spinal Deformities in Children Severely Affected with Spinal Muscular Atrophy after Gene Therapy with Onasemnogene Abeparvovec—Preliminary Results
Venla Soini, Gudrun Schreiber, Bernd Wilken et al. (4 authors)
Children
Open Access
Published: Jun 2023
14 citations
14 citations
239 days after retraction
In-depth comparison of Anc80L65 and AAV9 retinal targeting and characterization of cross-reactivity to multiple AAV serotypes in humans
Maura K. Schwartz, Shibi Likhite, Tatyana A. Vetter et al. (9 authors)
Molecular Therapy — Methods & Clinical Development
Open Access
Published: May 2023
3 citations
3 citations
222 days after retraction
MiR34 contributes to spinal muscular atrophy and AAV9-mediated delivery of MiR34a ameliorates the motor deficits in SMA mice
Tai‐Heng Chen, Shih-Hsin Chang, Yu-Fu Wu et al. (14 authors)
Molecular Therapy — Nucleic Acids
Open Access
Published: Mar 2023
12 citations
12 citations
160 days after retraction
Immune responses in the mammalian inner ear and their implications for AAV-mediated inner ear gene therapy
Yasuko Ishibashi, Cathy Yea Won Sung, M’hamed Grati et al. (4 authors)
Hearing Research
Published: Mar 2023
15 citations
15 citations
156 days after retraction
SMN2 Splicing Modification by Small Molecules – A Blueprint to Tackle the Underlying Genetic Cause of Many Underserved Diseases
Hasane Ratni, Martin Ebeling, R. Scalco et al. (5 authors)
The Royal Society of Chemistry eBooks
Published: Feb 2023
120 days after retraction
AAV Engineering for Improving Tropism to the Central Nervous System
Muhammad S Ghauri, Li Ou
Biology
Open Access
Published: Jan 2023
35 citations
35 citations
112 days after retraction
An isogenic human iPSC model unravels neurodevelopmental abnormalities in SMA
Tobias Graß, Ines Rosignol, J Thomas et al. (9 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jan 2023
2 citations
2 citations
89 days after retraction
Isogenic Patient-Derived Organoids Reveal Early Neurodevelopmental Defects in Spinal Muscular Atrophy Initiation
Tobias Graß, Ines Rosignol, J Thomas et al. (13 authors)
Unknown Journal
Published: Jan 2023
87 days after retraction
Therapeutics in paediatric genetic diseases: current and future landscape
Ai Ling Koh, Lynette Pei‐Chi Shek
Singapore Medical Journal
Open Access
Published: Jan 2023
6 citations
6 citations
87 days after retraction
Gene Therapy Drug Development for First-In-Human Study of Pediatric Diseases: Facilitating Change to Current Paradigms
Pranitha Rayapudi, Paulette M. Robinson, Ellery Mangas et al. (4 authors)
Medical Research Archives
Open Access
Published: Jan 2023
87 days after retraction
Development and Optimization of the Manufacturing Process for RNA-Splicing Modifier Risdiplam RG7916
Christian Moessner, Fabienne Hoffmann-Emery, Jean‐Michel Adam et al. (8 authors)
ACS symposium series
Published: Dec 2022
1 citation
1 citation
71 days after retraction
Ancestral library identifies conserved reprogrammable liver motif on AAV capsid
Eric Zinn, Carmen Unzu, Pauline F. Schmit et al. (20 authors)
Cell Reports Medicine
Open Access
Published: Nov 2022
20 citations
20 citations
26 days after retraction
Routes of administration for adeno-associated viruses carrying gene therapies for brain diseases
Kai Zhou, Jinming Han, Yafeng Wang et al. (5 authors)
Frontiers in Molecular Neuroscience
Open Access
Published: Oct 2022
28 citations
28 citations
20 days after retraction
SMN Is Physiologically Downregulated at Wild-Type Motor Nerve Terminals but Aggregates Together with Neurofilaments in SMA Mouse Models
Julio Franco-Espín, Alaó Gatius, José Á. Armengol et al. (8 authors)
Biomolecules
Open Access
Published: Oct 2022
7 citations
7 citations
14 days after retraction
IgG-cleavage protein allows therapeutic AAV gene delivery in passively immunized MPS IIIA mice
Tierra A. Bobo, Preston N. Samowitz, Michael I. Robinson et al. (8 authors)
Gene Therapy
Published: Oct 2022
5 citations
5 citations
11 days after retraction
Onasemnogene Abeparvovec in Type 1 Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis
Carlos Pascual‐Morena, Iván Cavero‐Redondo, Maribel Lucerón‐Lucas‐Torres et al. (6 authors)
Human Gene Therapy
Published: Sep 2022
16 citations
16 citations
14 days before retraction
Quick Stats
Total Citations:
696
Years Since Retraction:
3.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025